BioScrip Cash Flow - Quarterly (NASDAQ:BIOS)

Add to My Stocks
$3.02 $0.03 (1%) BIOS stock closing price Sep 18, 2018 (Closing)

The BioScrip cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows BioScrip profits, the balance sheet shows BioScrip debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. BioScrip saw a cash impact of $-0.18M from the buyback of BIOS shares. The cash flow statement helps in the BioScrip stock analysis by providing more information for evaluating changes in assets, liabilities and equities. BIOS decrease in investments stood at a value of $-6.95M for the latest quarter 2018 Q2.

View and download details of BioScrip cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-28.16M-13.01M-64.19M-61.14M-48.62M-19.42M-41.5M-29.03M-17.77M-9.53M
Depreciation Depletion Amortization Cash-Flow16.92M8.5M34.72M24.94M16.65M8.3M25.59M15.96M10.77M5.54M
Net Increase (Decrease) in Assets Liabilities-10.27M2.47M17.6M12.17M10.55M-1.05M-11.43M-14.57M-9.88M-1.5M
Cash From (used in) Discontinued Operations---5.5M-5.5M---0.42M-6.22M-6.22M-6.22M
Other Adjustments Net1.17M-3.15M16.6M18.62M16.38M1.14M-14.99M-4.66M1.5M-
Net Cash from (used by) Operating Activities
-20.33M-5.19M-0.76M-10.89M-5.03M-11.03M-42.76M-38.53M-21.58M-10.96M
Increase (Decrease) in Prop Plant And Equipment-6.95M-2.64M-8.68M-5.04M-4.29M-1.68M-5.46M-3.86M-4.33M-1.32M
Acquisition Disposition of Subsidiaires-------67.51M-67.51M--
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities---4.95M-4.95M-5.05M-5.13M----
Net Cash from (used by) Investment Activities
-6.95M-2.64M-13.63M-9.99M-9.34M-6.81M-72.98M-71.38M-4.33M-1.32M
Issuance (Purchase) of Equity Shares-0.18M-0.3M20.89M-20.77M5.05M83.06M-83.26M-
Issuance (Repayment) of Debt Securities8.82M-0.96M79.66M79.94M80.33M19.68M-13.62M-9.93M-6.4M-3.18M
Increase (Decrease) in Bank & Other Borrowings---55.3M-55.3M-55.3M-0.43M40.3M24M-15M8M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.98M19.69M-0.46M-0.05M-83.11M-0.09M-0.05M
Net Cash from (used by) Financing Activities
8.64M-1.26M44.28M44.33M45.34M24.24M109.74M97.17M61.77M4.75M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-18.64M-9.1M29.88M23.44M30.96M6.4M-6M-12.74M35.84M-7.52M
Cash & Equivalents at Beginning of Year44.41M9.56M15.57M-1M62.1M----
Cash & Equivalents at Year End25.77M35.3M39.45M33.01M40.53M15.96M9.56M2.83M51.42M8.05M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

BioScrip stock comparison chart provides an easy way to compare the stock price with peers along with details of BioScrip stock price history.
The statement of cash flows can be categorized into the following main sections:

  • BioScrip saw a negative change in Net Change in Cash and Cash Equivalents of $-18.64M till 2018 Q2. Apart from the BioScrip stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • BioScrip decreased its cash from operating activities to $-20.33M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-6.95M for BIOS till last quarter 2018 Q2 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $8.64M for BioScrip.

Key Financial Ratios For BioScrip Cash Flow